Bioventus Inc.
BVSNASDAQHealthcareMedical Devices
As of Oct 15, 2026 close
- Market cap
- $978.28M
- P/E (TTM)
- 17.96
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.47$15.89
- Volume (live)
- -
- Avg. volume (3M)
- 436.75K
Bioventus (BVS) Stock Price & Financial Analysis
Bioventus Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $13.69 - $13.91 |
|---|---|
| 52-Week High | $15.89 |
| 52-Week Low | $6.47 |
| Open | $13.73 |
| Volume (last close) | 295.61K |
| Average Volume (3M) | 436.75K |
| Revenue (TTM) | 581.85M |
|---|---|
| Net Income (TTM) | 54.46M |
| Free Cash Flow (TTM) | 94.29M |
| EPS (TTM) | $0.78 |
| Profit Margin | 9.36% |
| Operating Margin | 10.56% |
| Return on Equity (ROE) | 23.86% |
| Debt to Equity | 1.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 978.28M |
|---|---|
| Shares Outstanding | 70.84M |
| P/E Ratio (TTM) | 17.96 |
| Price to Sales (P/S) | 1.68 |
| Price to Book (P/B) | 4.28 |
| EV/EBITDA | 11.54 |
| 50-Day MA | $13.70 |
|---|---|
| 200-Day MA | $10.51 |
| 1-Year Change | +100.73% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Bioventus at a Glance
As of the Oct 15, 2026 close, Bioventus (BVS) has a market capitalization of $978.28M. The stock trades at 18.0× trailing earnings and 1.7× sales. Over the trailing twelve months it earned $54.46M on revenue of $581.85M (a 9.4% profit margin) and generated $94.29M of free cash flow. Revenue grew 3.1% year over year.
As of its latest reported balance sheet, it holds $29.46M in cash and securities against $248.45M of debt, a net debt position of $219.00M.
Bioventus does not currently pay a dividend.
The share price is up 100.7% over the past year. At $13.81 (the Oct 15, 2026 close) it sits within its 52-week range of $6.47 to $15.89, above its 200-day moving average of $10.51.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $17.50, 26.7% above the Oct 15, 2026 close.
Frequently Asked Questions About Bioventus
What is the current stock price for BVS?
As of the Oct 15, 2026 close, BVS stock trades at $13.81. The 52-week range is $6.47–$15.89, with a day range of $13.69–$13.91.
What is the P/E ratio for BVS?
As of the Oct 15, 2026 close, Bioventus's trailing twelve-month (TTM) P/E ratio is 18.0, meaning investors pay $18.0 for every $1 of annual earnings. Bioventus operates in the Healthcare sector.
Does BVS pay dividends?
Bioventus does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BVS?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for BVS is Buy. The average 12-month price target is $17.50, a 26.7% upside from the Oct 15, 2026 close of $13.81.
What is the market cap of BVS?
As of the Oct 15, 2026 close, Bioventus's market capitalization is $978.3M, classifying it as a small-cap company. Bioventus operates in the Healthcare sector within the Medical Devices industry.